ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,344Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 50

$1.07M Total Retail Price of All Prescriptions

Rank: 4 out of 50

383 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 383 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 383 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 13,349 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 461 394 1 3
LISINOPRIL 406 328 2 8
POTASSIUM CHLORIDE 341 279 3 9
NAMENDA 338 296 4 25
DONEPEZIL HCL 325 298 5 20
METOPROLOL TARTRATE 298 226 6 12
OMEPRAZOLE 294 215 7 7
AMLODIPINE BESYLATE 257 203 8 6
QUETIAPINE FUMARATE 255 214 9 52
LEVOTHYROXINE SODIUM 254 217 10 2
LANTUS 245 170 11 38
SIMVASTATIN 242 207 12 5
POLYETHYLENE GLYCOL 3350 235 174 13 48
TRAMADOL HCL 234 200 14 11
GABAPENTIN 234 179 14 13
DIVALPROEX SODIUM 223 168 16 64
CITALOPRAM HBR 213 152 17 24
WARFARIN SODIUM 207 206 18 19
HYDROCODONE-ACETAMINOPHEN 190 158 S3 19 1
METFORMIN HCL 190 158 19 4
MEGESTROL ACETATE 189 178 R 21 77
DIGOXIN 185 161 22 40
TRAZODONE HCL 185 126 22 44
RISPERIDONE 179 156 24 50
RANITIDINE HCL 177 170 25 51
EXELON 164 139 26 91
FLUOXETINE HCL 153 120 27 60
NEXIUM 152 119 28 15
MIRTAZAPINE 143 125 29 73
CLONIDINE HCL 142 116 30 23
ESCITALOPRAM OXALATE 139 119 31 43
PANTOPRAZOLE SODIUM 139 103 31 32
HYDROCHLOROTHIAZIDE 127 96 33 10
PRAVASTATIN SODIUM 124 115 34 14
CYMBALTA 121 104 35 45
DOXAZOSIN MESYLATE 121 89 35 58
PHENYTOIN SODIUM EXTENDED 120 88 37 91
TAMSULOSIN HCL 118 107 38 31
ZOLPIDEM TARTRATE 118 102 38 18
FAMOTIDINE 118 106 38 98
CLOPIDOGREL 117 107 41 29
OLANZAPINE 113 79 42 96
DIVALPROEX SODIUM ER 113 92 42 112
METOPROLOL SUCCINATE 112 103 44 22
PREDNISONE 111 104 45 33
NOVOLIN R 108 87 46 129
ABILIFY 104 83 47 151
PAROXETINE HCL 102 83 48 81
ZIPRASIDONE HCL 100 42 49 131
HUMULIN R 95 72 50 153
SEROQUEL 93 78 51 110
CARVEDILOL 91 85 52 27
LEVOFLOXACIN 89 79 53 130
FLUTICASONE PROPIONATE 86 65 54 75
BACLOFEN 85 72 55 145
CARBIDOPA-LEVODOPA 84 81 56 139
ATENOLOL 81 42 57 26
RAMIPRIL 75 47 58 59
TOPIRAMATE 75 50 58 165
TRIAMTERENE-HYDROCHLOROTHIAZID 75 63 58 159
PROMETHAZINE HCL 75 64 R 58 69
PLAVIX 74 71 62 42
SANTYL 72 66 63 161
LOSARTAN POTASSIUM 70 67 64 37
LEVETIRACETAM 70 46 64 148
DOXYCYCLINE HYCLATE 66 56 66 115
SERTRALINE HCL 66 52 66 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 49 68 94
CLOZAPINE 64 42 69 157
FINASTERIDE 62 46 70 128
DIOVAN 62 46 70 35
THEOPHYLLINE ANHYDROUS 62 37 70 156
ALLOPURINOL 60 32 73 34
FELODIPINE ER 60 60 73 223
SEROQUEL XR 60 52 73 121
CEFUROXIME 60 49 73 223
LYRICA 59 47 77 55
OXYBUTYNIN CHLORIDE ER 59 59 77 120
BENZTROPINE MESYLATE 58 21 R 79 100
LEXAPRO 58 45 79 228
ATORVASTATIN CALCIUM 56 45 81 21
AZITHROMYCIN 55 53 82 36
ROPINIROLE HCL 54 41 83 101
NAPROXEN 53 39 84 62
GEMFIBROZIL 50 23 85 133
ADVAIR DISKUS 50 32 85 54
BUSPIRONE HCL 50 50 85 133
CIPROFLOXACIN HCL 50 48 85 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.